BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34505883)

  • 1. Plasma and rhADAMTS13 reduce trauma-induced organ failure by restoring the ADAMTS13-VWF axis.
    Kleinveld DJB; Simons DDG; Dekimpe C; Deconinck SJ; Sloos PH; Maas MAW; Kers J; Muia J; Brohi K; Voorberg J; Vanhoorelbeke K; Hollmann MW; Juffermans NP;
    Blood Adv; 2021 Sep; 5(17):3478-3491. PubMed ID: 34505883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Von Willebrand factor promotes radiation-induced intestinal injury (RIII) development and its cleavage enzyme rhADAMTS13 protects against RIII by reducing inflammation and oxidative stress.
    Xu J; He J; Zhou YL; Weng Z; Li M; Wang ZX; He Y
    Free Radic Biol Med; 2024 Jan; 210():1-12. PubMed ID: 37956910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Human ADAMTS13 Treatment Improves Myocardial Remodeling and Functionality After Pressure Overload Injury in Mice.
    Witsch T; Martinod K; Sorvillo N; Portier I; De Meyer SF; Wagner DD
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29367415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Traumatic injury results in prolonged circulation of ultralarge von Willebrand factor and a reduction in ADAMTS13 activity.
    Dyer MR; Plautz WE; Ragni MV; Alexander W; Haldeman S; Sperry JL; Guyette FX; Zuckerbraun BS; Rollins-Raval MA; Raval JS; Neal MD;
    Transfusion; 2020 Jun; 60(6):1308-1318. PubMed ID: 32441353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. rhADAMTS13 reduces oxidative stress by cleaving VWF in ischaemia/reperfusion-induced acute kidney injury.
    Zhou S; Guo J; Liao X; Zhou Q; Qiu X; Jiang S; Xu N; Wang X; Zhao L; Hu W; Xie L; Xie P; Cui Y; Yang Y; Patzak A; Persson PB; Mao J; Lai EY
    Acta Physiol (Oxf); 2022 Mar; 234(3):e13778. PubMed ID: 34989474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAMTS13 inhibits oxidative stress and ameliorates progressive chronic kidney disease following ischaemia/reperfusion injury.
    Zhou S; Guo J; Zhao L; Liao Y; Zhou Q; Cui Y; Hu W; Chen J; Ren X; Wei Q; Jiang S; Zheng Y; Li L; Wilcox CS; Persson PB; Patzak A; Tian J; Yin Lai E
    Acta Physiol (Oxf); 2021 Mar; 231(3):e13586. PubMed ID: 33226724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced cleavage of von willebrand factor by ADAMTS13 is associated with microangiopathic acute kidney injury following trauma.
    Plautz WE; Haldeman SH; Dyer MR; Sperry JL; Guyette FX; Loughran PA; Alvikas J; Hassoune A; Hoteit L; Alsaadi N; Zuckerbraun BS; Rollins-Raval MA; Raval JS; Mota RI; Neal MD;
    Blood Coagul Fibrinolysis; 2022 Jan; 33(1):14-24. PubMed ID: 34889809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome.
    Hugenholtz GC; Adelmeijer J; Meijers JC; Porte RJ; Stravitz RT; Lisman T
    Hepatology; 2013 Aug; 58(2):752-61. PubMed ID: 23468040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Overview of Laboratory Testing for ADAMTS13.
    Favaloro EJ; Pasalic L
    Methods Mol Biol; 2023; 2663():481-486. PubMed ID: 37204731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ratio of von Willebrand factor propeptide to ADAMTS13 is associated with severity of sepsis.
    Fukushima H; Nishio K; Asai H; Watanabe T; Seki T; Matsui H; Sugimoto M; Matsumoto M; Fujimura Y; Okuchi K
    Shock; 2013 May; 39(5):409-14. PubMed ID: 23481506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice.
    Dhanesha N; Doddapattar P; Chorawala MR; Nayak MK; Kokame K; Staber JM; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1332-1338. PubMed ID: 28495930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease.
    Reardon B; Pasalic L; Favaloro EJ
    J Cardiovasc Dev Dis; 2021 Sep; 8(9):. PubMed ID: 34564132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tranexamic acid on endothelial von Willebrand factor/ADAMTS-13 response to in vitro shock conditions.
    Diebel LN; Liberati DM
    J Trauma Acute Care Surg; 2023 Feb; 94(2):273-280. PubMed ID: 36322025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19.
    Turecek PL; Peck RC; Rangarajan S; Reilly-Stitt C; Laffan MA; Kazmi R; James I; Dushianthan A; Schrenk G; Gritsch H; Ewenstein BM; Mellgard B; Erdlenbruch W; Jain N; Binder NB; Mumford AD
    Thromb Res; 2021 May; 201():100-112. PubMed ID: 33662796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition.
    Larkin D; de Laat B; Jenkins PV; Bunn J; Craig AG; Terraube V; Preston RJ; Donkor C; Grau GE; van Mourik JA; O'Donnell JS
    PLoS Pathog; 2009 Mar; 5(3):e1000349. PubMed ID: 19300493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.
    Pruss CM; Golder M; Bryant A; Hegadorn C; Haberichter S; Lillicrap D
    J Thromb Haemost; 2012 May; 10(5):940-50. PubMed ID: 22372972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VWF/ADAMTS13 Imbalance, But Not Global Coagulation or Fibrinolysis, Is Associated With Outcome and Bleeding in Acute Liver Failure.
    Driever EG; Stravitz RT; Zhang J; Adelmeijer J; Durkalski V; Lee WM; Lisman T
    Hepatology; 2021 May; 73(5):1882-1891. PubMed ID: 32767567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy.
    Chung MC; Popova TG; Jorgensen SC; Dong L; Chandhoke V; Bailey CL; Popov SG
    J Biol Chem; 2008 Apr; 283(15):9531-42. PubMed ID: 18263586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality.
    Sinkovits G; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Mező B; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
    Thromb Haemost; 2022 Feb; 122(2):240-256. PubMed ID: 35062036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis.
    Xu X; Feng Y; Jia Y; Zhang X; Li L; Bai X; Jiao L
    Thromb Res; 2022 Oct; 218():83-98. PubMed ID: 36027630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.